Vaccine News and Research

Latest Vaccine News and Research

Australians consider medical research more important than tax cuts and border protection

Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.

10 Sep 2005

Two die from mosquito-borne disease, experts say public must protect themslves from bites

According to health officials, a rare mosquito-borne disease has killed a young girl and an elderly man who lived in neighboring towns, and they are urging people to protect themselves against the insects.

10 Sep 2005

Two die from mosquito-borne disease, experts say public must protect themslves from bites

According to health officials, a rare mosquito-borne disease has killed a young girl and an elderly man who lived in neighboring towns,and they are urging people to protect themselves against the insects.

7 Sep 2005

Stressgen granted new U.S. patent for treatment of Hepatitis B

Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted Patent Number 6,921,534 covering fusion protein compositions comprised of a hepatitis B virus (HBV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins, and methods of treating an HBV infection using these fusion proteins.

7 Sep 2005

Researchers develop screening test for cells that activate immune system

UT Southwestern Medical Center researchers are the first to create a large-scale, cell-based screening method that identifies which compounds activate immune-response cells that hold promise for future cancer-fighting vaccines.

7 Sep 2005

Collaborators seek parasite invasion blockers

A malaria research team, including WEHI Structural Biologist, Professor Ray Norton, has received a US$1 million grant from the US National Institutes of Health to develop more effective malaria treatments.

7 Sep 2005

Generex Biotechnology awarded Australian patent

Generex Biotechnology Corporation today announced that it has been granted a patent by the Australian Patent Office titled "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation."

6 Sep 2005

Shot in the arm for vaccines

A Flinders University research program to develop new forms of vaccine against infectious diseases has received over $3 million in funding from the United States Government's National Institutes of Health.

6 Sep 2005

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Coronaviruses - the family of viruses that causes the common cold - gained widespread recognition when the deadly severe acute respiratory syndrome, familiarly known as SARS, killed at least 800 people in 2003.

6 Sep 2005

The Measles Initiative partnership a significant reason for success

The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.

6 Sep 2005

New vaccine with the potential to protect against fungal pathogens

A group of scientists in Italy have developed a vaccine with the potential to protect against fungal pathogens that commonly infect humans, according to a study by Torosantucci and colleagues in the September 5 issue of The Journal of Experimental Medicine.

5 Sep 2005

Chicken pox vaccine associated with shingles epidemic

New research published in the International Journal of Toxicology (IJT) by Gary S. Goldman, Ph.D., reveals high rates of shingles (herpes zoster) in Americans since the government's 1995 recommendation that all children receive chicken pox vaccine.

1 Sep 2005

GlaxoSmithKline acquires vaccine R&D and manufacturing plant in the U.S.

GlaxoSmithKline has announced that it is expanding its ability to increase vaccines supplies for Americans by acquiring a vaccine research and production facility in Marietta, Pennsylvania.

1 Sep 2005

New vaccine approved for U.S. just in time for flu season

A new flu vaccine has been approved by U.S. health officials in an attempt to bolster up supplies after last season's shortage.

31 Aug 2005

Emergent Biosolutions' typhoid vaccine achieves positive results in Phase II clinical study

Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.

30 Aug 2005